Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Name: Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
Published: 2024
License: Public Domain

Cerenome · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

brain-cancer brain-tumor glioblastoma glioma radiotherapy

glioma, brain tumor, radiotherapy, glioblastoma, recurrent glioblastoma, rhenium, rhenium nanoliposome, brain cancer, gbm, high grade glioma, glioblastoma multiform, grade iv astrocytoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 810641
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.